SLC5A2 and heart failure: Angiotensin receptor blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor–neprilysin inhibitors, and sodium-glucose cotransporter 2 inhibitors have been shown to reduce the progression of heart failure, ameliorate symptoms, and prevent its complications [23].